Table 2.
(DIII-S, S)P X 1 | (DIII-S, S)P X 2 | (DIII-S)N X 2 | |||
---|---|---|---|---|---|
LNI a | PRNT50 b | LNI | PRNT50 | LNI | PRNT50 |
0.64 | 1:10 | 1.41 | 1:160 | 0.21 | 1:20 |
0.81 | 1.51 | 0.33 | |||
0.64 | 1.51 | 0.21 | |||
0.51 | 1.81 | ||||
1.81 | |||||
0.51 | |||||
0.41 |
Individual LNI titers are presented in the same order as for Table 1. a Neutralizing titer expressed as the logarithmic neutralization index (LNI), where samples coming from MVvac2 and MVvac2(HBsAg)N immune animals (eight samples) set the zero for neutralization of DV2 infectivity (see text); b PRNT50 obtained in pooled serum samples for each experimental group, all of tested pre-immune samples lacked reactivity against DV2, PRNT < 1:10, LNI ~ 0.